Wall Street is positive on Atea Pharmaceuticals Inc (AVIR). On average, analysts give the stock a Hold rating. The average price target is $3, which means analysts expect the stock to decline by -28.40% over the next twelve months.
That average ranking earns the stock an Analyst Rating of 4, which is better than 4% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating AVIR a Hold today. Find out what this means to you and get the rest of the rankings on AVIR!
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With Atea Pharmaceuticals Inc Stock Today?
Atea Pharmaceuticals Inc (AVIR) stock is trading at $4.19 as of 3:23 PM on Thursday, Feb 15, a rise of $0.17, or 4.23% from the previous closing price of $4.02. The stock has traded between $4.03 and $4.22 so far today. Volume today is light. So far 147,185 shares have traded compared to average volume of 574,846 shares.
Click Here to get the full Stock Report for Atea Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
